BSI’s goal is to make QS-21 accessible to a wider range of vaccines and populations, particularly in low-income countries.

Good evening and welcome to Dyadic International's Year-End 2024 Conference Call. Currently, all participants are in a listen-only mode. Following management's prepared remarks, there will be a brief ...

GSK remains on fairly stable financial footing, with a debt/EBITDA ratio of 2.8 at the end of 2024 and Haleon taking on close to GBP 10 billion of GSK's debt in the 2022 divestment. With the improving ...

Nitisinone, a drug for rare diseases, kills mosquitoes when present in human blood and may become a new tool to fight malaria ...

The Trump administration intends to terminate the United States’ financial support for Gavi, the organization that has helped ...